Research Article

Increased Circulating Chemerin in Relation to Chronic Microvascular Complications in Patients with Type 2 Diabetes

Table 1

Baseline characteristics of patients with and without microvascular complications.

AllWithout complicationWith complicationp

Number (n)598131467NS
Age (years)54.56(12.14)53.91 (12.21)54.74(12.12)NS
Sex (male/female)383/21590/41293/174NS
Duration of diabetes (years)△8(3,13)2(0.8,9)10(5,15)<0.001
Waist circumference (cm)87.30(9.40)86.63 (11.12)87.37(9.23)NS
BMI (kg/m2)25.38(3.52)24.91(3.46)25.51(3.52)NS
SBP (mmHg)127.05(14.57)125.01(13.26)127.63(14.88)NS
DBP (mmHg)79.28(6.62)78.37(7.47)79.53(6.35)NS
Glycated hemoglobin (%)8.71(1.87)8.03(1.45)8.91(1.92)<0.001
Triglycerides (mmol/l) △1.65(1.17,2.57)1.62(1.15,2.21)1.70(1.19,2.76)NS
Total cholesterol (mmol/l)4.76(1.05)4.62(1.03)4.79(1.05)NS
HDL cholesterol (mmol/l)1.09(0.33)1.07(0.30)1.10(0.34)NS
LDL cholesterol (mmol/l)2.81(0.84)2.77(0.75)2.82(0.87)NS
Scr (umol/l)61.70(23.12)55.53(13.58)63.44(24.89)0.001
UAE (mg/24h)△22.4(12.4,107.1)
13.2(9,17.0)36.8(14.4,188.76)<0.001
hs-CRP (mg/L) △4.70(1.8,8.60)3.6(1.2,6.6)5.0 (2.0,8.8)0.021
Chemerin (ng/ml)114.78(43.62)97.69(40.27)119.54(43.37)<0.001
Medication
 Oral hypoglycemic agents139 (23.2%)33(25.1%)106(22.69%)NS
 Insulin459 (76.8%)98(74.9%)361(78.31%)NS
Hypertension (%)364(60.8%)71(54.19%)293(62.7%)NS
Microvascular complications
 Nephropathy (%)261(43.6)
 Retinopathy (%)209(34.9)
 Neuropathy (%)201(33.6)
 One complication (%)322(53.8)
 Two complications (%)86(14.4)
 Three complications (%)59(9.9)

Numerical variables are expressed as the mean with SD and median (interquartile range). Categorical variables were presented as number (percentage). P-value for difference between the groups was calculated from the analysis of Student’s t test.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; Scr, serum creatinine; UAE, urinary albumin excretion; hs-CRP, high sensitivity C-reactive protein; NS, not significant.
△Natural logarithmic transformation was used in analysis.